1-4 of 4
Petri Bono
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy, molecular and translational analysis of TP53-mutated HR-MDS with bexmarilimab and azacitidine: Updated results from the bexmab Phase 1/2 study

Free
Amer Zeidan, Anthony Selwyn Stein, Johanna Rimpiläinen, Marja Pyörälä, Timo Siitonen, Brian Ball, Mikko Myllymäki, Joshua Zeidner, Dr. Emma Searle, Ruth Witherall, Petri Bono, Aneel Nimba, Joab Williamson, Sofia Aakko, Maija Hollmén, Mika Kontro, Naval Daver
Journal: Blood
Blood (2025) 146 (Supplement 1): 236.
https://doi.org/10.1182/blood-2025-236
Published: 2025
Journal Articles

Transfusion independence, hematological improvement and associated safety outcomes with bexmarilimab and azacitidine in HR-MDS: Results of the bexmab Phase 1/2 study

Free
Mika Kontro, Anthony Selwyn Stein, Johanna Rimpiläinen, Marja Pyörälä, Timo Siitonen, Brian Ball, Mikko Myllymäki, Joshua Zeidner, Dr. Emma Searle, Ruth Witherall, Petri Bono, Aneel Nimba, Joab Williamson, Sofia Aakko, Maija Hollmén, Amer Zeidan, Naval Daver
Journal: Blood
Blood (2025) 146 (Supplement 1): 5627.
https://doi.org/10.1182/blood-2025-5627
Published: 2025
Journal Articles

Prognostic Impact of Microvessel Density in Follicular Lymphoma Patients Treated with Immunochemotherapy

Free
Minna Taskinen, Petri Bono, Sirpa Leppä
Journal: Blood
Blood (2008) 112 (11): 2836.
https://doi.org/10.1182/blood.V112.11.2836.2836
Published: 2008
Journal Articles

Serum KIT and KIT ligand levels in patients with gastrointestinal stromal tumors treated with imatinib

Free
Clinical Trials & Observations
Petri Bono, Andreas Krause, Margaret von Mehren, Michael C. Heinrich, Charles D. Blanke, Sasa Dimitrijevic, George D. Demetri, Heikki Joensuu
Journal: Blood
Blood (2004) 103 (8): 2929–2935.
https://doi.org/10.1182/blood-2003-10-3443
Published: 2004